Log in or Sign up for Free to view tailored content for your specialty!
Emerging Diseases News
FDA advisors vote in favor of Pfizer’s RSV vaccine to protect infants
An FDA advisory committee on Thursday voted in favor of a respiratory syncytial virus vaccine that would be administered to pregnant people to protect their infants.
To understand long COVID’s pathogenesis, consider fibromyalgia
The current understanding of long COVID’s pathogenesis may be better served by looking to other diseases and syndromes, particularly fibromyalgia, according to a speaker at the 2023 Biologic Therapies Summit.
Log in or Sign up for Free to view tailored content for your specialty!
Jynneos vaccine offers ‘substantial’ protection against mpox, studies find
The Jynneos vaccine was up to 86% effective at preventing mpox in people who received two doses during the United States outbreak, according to three studies published Thursday.
Additional COVID-19 vaccine doses may ‘bully’ response in immunosuppressed patients
Additional COVID-19 vaccine doses can occasionally “bully” a humoral response in patients who are immunocompromised, according to a presenter at the 2023 Biologic Therapies Summit.
Hearts from donors with COVID-19 at time of death may confer worse survival for recipients
Transplant recipients with donor hearts from people who had active COVID-19 at time of death had worse 6-month and 1-year survival outcomes than those who had hearts from donors recovered from or without COVID-19, researchers reported.
End of COVID emergency marks ‘less government effort,’ greater role for rheumatologists
Communication between rheumatologists and patients with immune-mediated conditions will be essential for navigating COVID-19 in the endemic phase, according to a presenter at the Biologic Therapies Summit.
WHO: Mpox also no longer a global public health emergency
WHO this week ended the public health emergency of international concern declared last year for the global mpox outbreak.
Bacterial infections less common among infants with SARS-CoV-2
A study of more than 14,000 febrile infants found that UTIs, bacteremia and bacterial meningitis were less common among those who tested positive for SARS-CoV-2 than those who did not, according to findings published in JAMA Network Open.
Q&A: What impact did ID experts have on the COVID-19 pandemic?
Throughout the COVID-19 pandemic, infectious disease experts made contributions to help control the outbreak and improve public understanding of the new disease.
What happens after COVID-19 emergencies end?
The public health and national emergencies declared by the United States in the early days of the COVID-19 pandemic expire at the end of the day on May 11.